- Home
- KELYB vs AUTL Comparison
KELYB vs AUTL Comparison
Compare KELYB & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KELYB
- AUTL
- Stock Information
- Founded
- KELYB 1946
- AUTL 2014
- Country
- KELYB United States
- AUTL United Kingdom
- Employees
- KELYB N/A
- AUTL N/A
- Industry
- KELYB Professional Services
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KELYB Consumer Discretionary
- AUTL Health Care
- Exchange
- KELYB Nasdaq
- AUTL Nasdaq
- Market Cap
- KELYB 321.6M
- AUTL 368.6M
- IPO Year
- KELYB N/A
- AUTL 2018
- Fundamental
- Price
- KELYB $8.80
- AUTL $1.36
- Analyst Decision
- KELYB
- AUTL Strong Buy
- Analyst Count
- KELYB 0
- AUTL 3
- Target Price
- KELYB N/A
- AUTL $8.33
- AVG Volume (30 Days)
- KELYB 447.0
- AUTL 3.7M
- Earning Date
- KELYB 11-06-2025
- AUTL 11-12-2025
- Dividend Yield
- KELYB 3.31%
- AUTL N/A
- EPS Growth
- KELYB N/A
- AUTL N/A
- EPS
- KELYB N/A
- AUTL N/A
- Revenue
- KELYB $4,392,800,000.00
- AUTL $51,128,000.00
- Revenue This Year
- KELYB $4.55
- AUTL $643.50
- Revenue Next Year
- KELYB $5.01
- AUTL $108.69
- P/E Ratio
- KELYB N/A
- AUTL N/A
- Revenue Growth
- KELYB 0.46
- AUTL 406.67
- 52 Week Low
- KELYB $8.80
- AUTL $1.11
- 52 Week High
- KELYB $15.50
- AUTL $3.45
- Technical
- Relative Strength Index (RSI)
- KELYB 27.96
- AUTL 48.00
- Support Level
- KELYB $12.96
- AUTL $1.20
- Resistance Level
- KELYB $13.47
- AUTL $1.49
- Average True Range (ATR)
- KELYB 0.09
- AUTL 0.10
- MACD
- KELYB -0.59
- AUTL 0.01
- Stochastic Oscillator
- KELYB 0.00
- AUTL 51.56
About KELYB Kelly Services Inc. Class B
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.